Global Pharmaceutical Analytical Testing Outsourcing Market Growth, Size, Trends Analysis - By Service, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Pharmaceutical Analytical Testing Outsourcing Market Introduction and Overview

According to SPER market research, 'Global Pharmaceutical Analytical Testing Outsourcing Market Size- By Service, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Pharmaceutical Analytical Testing Outsourcing Market is predicted to reach 20.87 billion by 2034 with a CAGR of 8.74%.

Pharmaceutical analytical testing outsourcing is contracting with outside service providers to analyse pharmaceutical products, raw materials, and intermediates. Such providers, which may include contract research organizations (CROs), contract manufacturing organizations (CMOs), or other specialized laboratories, conduct a range of analytical tests to evaluate the quality, purity, potency, and safety of pharmaceutical substances.

Restraints: Although there are numerous advantages, outsourcing pharmaceutical analytical testing entails considerable costs that may overwhelm smaller enterprises or those operating with restricted finances. The charges imposed by external laboratories for complex testing services can be considerable, especially for high-level analytical methods such as mass spectrometry or nuclear magnetic resonance (NMR) spectroscopy.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Service, By End-User

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered SGS SociA(C)tA(C) GA(C)nA(C)rale de Surveillance SA, Labcorp, Eurofins Scientific, Pace Analytical Services LLC, Intertek Group plc, Thermo Fisher Scientific Inc, Wuxi AppTec, BA Sciences, Charles River Laboratories, West Pharmaceutical Services, Inc.

Global Pharmaceutical Analytical Testing Outsourcing Market Segmentation:

By Service: Based on the Service, Global Pharmaceutical Analytical Testing Outsourcing Market is segmented as; Bioanalytical Testing, Method Development & Validation, Stability Testing, Others.

By End-User: Based on the End-User, Global Pharmaceutical Analytical Testing Outsourcing Market is segmented as; Pharmaceutical Companies, Biopharmaceutical Companies, Contract Research Organizations.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Product Code: PHAR2519

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Pharmaceutical Analytical Testing Outsourcing Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Pharmaceutical Analytical Testing Outsourcing Market

7. Global Pharmaceutical Analytical Testing Outsourcing Market, By Service (USD Million) 2021-2034

7.1. Bioanalytical Testing
- 7.1.1. Clinical
- 7.1.2. Non-Clinical
7.2. Method Development & Validation
- 7.2.1. Extractable & Leachable
- 7.2.2. Impurity Method
- 7.2.3. Technical Consulting
- 7.2.4. Others
7.3. Stability Testing
- 7.3.1. Drug Substance
- 7.3.2. Stability Indicating Method Validation
- 7.3.3. Accelerated Stability Testing
- 7.3.4. Photostability Testing
- 7.3.5. Others
7.4. Others

8. Global Pharmaceutical Analytical Testing Outsourcing Market, By End-User (USD Million) 2021-2034

8.1. Pharmaceutical Companies
8.2. Biopharmaceutical Companies
8.3. Contract Research Organizations

9. Global Pharmaceutical Analytical Testing Outsourcing Market, (USD Million) 2021-2034

9.1. Global Pharmaceutical Analytical Testing Outsourcing Market Size and Market Share

10. Global Pharmaceutical Analytical Testing Outsourcing Market, By Region, (USD Million) 2021-2034

10.1. Asia-Pacific
- 10.1.1. Australia
- 10.1.2. China
- 10.1.3. India
- 10.1.4. Japan
- 10.1.5. South Korea
- 10.1.6. Rest of Asia-Pacific
10.2. Europe
- 10.2.1. France
- 10.2.2. Germany
- 10.2.3. Italy
- 10.2.4. Spain
- 10.2.5. United Kingdom
- 10.2.6. Rest of Europe
10.3. Middle East and Africa
- 10.3.1. Kingdom of Saudi Arabia
- 10.3.2. United Arab Emirates
- 10.3.3. Qatar
- 10.3.4. South Africa
- 10.3.5. Egypt
- 10.3.6. Morocco
- 10.3.7. Nigeria
- 10.3.8. Rest of Middle-East and Africa
10.4. North America
- 10.4.1. Canada
- 10.4.2. Mexico
- 10.4.3. United States
10.5. Latin America
- 10.5.1. Argentina
- 10.5.2. Brazil
- 10.5.3. Rest of Latin America

11. Company Profile

11.1. SGS SociA(C)tA(C) GA(C)nA(C)rale de Surveillance SA
- 11.1.1. Company details
- 11.1.2. Financial outlook
- 11.1.3. Product summary
- 11.1.4. Recent developments
11.2. Labcorp
- 11.2.1. Company details
- 11.2.2. Financial outlook
- 11.2.3. Product summary
- 11.2.4. Recent developments
11.3. Eurofins Scientific
- 11.3.1. Company details
- 11.3.2. Financial outlook
- 11.3.3. Product summary
- 11.3.4. Recent developments
11.4. Pace Analytical Services LLC
- 11.4.1. Company details
- 11.4.2. Financial outlook
- 11.4.3. Product summary
- 11.4.4. Recent developments
11.5. Intertek Group plc
- 11.5.1. Company details
- 11.5.2. Financial outlook
- 11.5.3. Product summary
- 11.5.4. Recent developments
11.6. Thermo Fisher Scientific Inc
- 11.6.1. Company details
- 11.6.2. Financial outlook
- 11.6.3. Product summary
- 11.6.4. Recent developments
11.7. Wuxi AppTec
- 11.7.1. Company details
- 11.7.2. Financial outlook
- 11.7.3. Product summary
- 11.7.4. Recent developments
11.8. BA Sciences
- 11.8.1. Company details
- 11.8.2. Financial outlook
- 11.8.3. Product summary
- 11.8.4. Recent developments
11.9. Charles River Laboratories
- 11.9.1. Company details
- 11.9.2. Financial outlook
- 11.9.3. Product summary
- 11.9.4. Recent developments
11.10. West Pharmaceutical Services, Inc
- 11.10.1. Company details
- 11.10.2. Financial outlook
- 11.10.3. Product summary
- 11.10.4. Recent developments
11.11. Others